{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T20:16:01Z","timestamp":1774728961995,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ajo.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,5,17]],"date-time":"2014-05-17T10:46:34Z","timestamp":1400323594000},"page":"270-276.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Outcomes Following Boston Type 1 Keratoprosthesis Implantation in Aniridia Patients at the University of Montreal"],"prefix":"10.1016","volume":"158","author":[{"given":"Salima I.","family":"Hassanaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia C.","family":"Talajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Harissi-Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajo.2014.05.009_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1755-3768.2008.01427.x","article-title":"Aniridia: current pathology and management","volume":"86","author":"Lee","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.05.009_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1399-0004.2010.01372.x","article-title":"Clinical and molecular aspects of aniridia","volume":"77","author":"Kokotas","year":"2010","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.ajo.2014.05.009_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ajo.2011.10.027","article-title":"Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia","volume":"153","author":"Bakhtiari","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2014.05.009_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(14)73581-0","article-title":"Results of penetrating keratoplasty in aniridia","volume":"115","author":"Kremer","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.05.009_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00003226-199609000-00004","article-title":"Recurrent keratopathy after penetrating keratoplasty for aniridia","volume":"15","author":"Gomes","year":"1996","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2014.05.009_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0161-6420(02)01451-3","article-title":"Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique","volume":"110","author":"Holland","year":"2003","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2014.05.009_bib7","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/ICO.0b013e31823f7765","article-title":"Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure","volume":"31","author":"Kang","year":"2012","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2014.05.009_bib8","doi-asserted-by":"crossref","first-page":"1779.e1771","DOI":"10.1016\/j.ophtha.2006.05.015","article-title":"Results from the multicenter Boston Type 1 Keratoprosthesis Study","volume":"113","author":"Zerbe","year":"2006","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2014.05.009_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICO.0b013e31818b8bfa","article-title":"Boston type 1 keratoprosthesis: the University of California Davis experience","volume":"28","author":"Bradley","year":"2009","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2014.05.009_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ophtha.2008.12.058","article-title":"The Boston type I keratoprosthesis: improving outcomes and expanding indications","volume":"116","author":"Aldave","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2014.05.009_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/ICU.0b013e3283477d0d","article-title":"Expanding indications for the Boston keratoprosthesis","volume":"22","author":"Colby","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2014.05.009_bib12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ophtha.2010.12.032","article-title":"Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis","volume":"118","author":"Greiner","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.05.009_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/17469899.1.1.41","article-title":"Introduction to the use of the Boston keratoprosthesis","volume":"1","author":"Dohlman","year":"2006","journal-title":"Expert Rev Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2014.05.009_bib14","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ajo.2005.06.041","article-title":"Keratoprosthesis: the Dohlman-Doane device","volume":"140","author":"Aquavella","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.05.009_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajo.2007.04.036","article-title":"Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study","volume":"144","author":"Akpek","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2014.05.009_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/ICO.0b013e318281724a","article-title":"Treatment of aniridia with Boston Type I Keratoprosthesis","volume":"32","author":"Rixen","year":"2013","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2014.05.009_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2011.07.022","article-title":"Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery","volume":"153","author":"Talajic","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.05.009_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICO.0b013e31820f7a32","article-title":"Glaucoma associated with Boston type I keratoprosthesis","volume":"31","author":"Kamyar","year":"2012","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2014.05.009_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bjo.2010.189571","article-title":"Delayed suprachoroidal haemorrhage following Boston Keratoprosthesis in two aniridic patients","volume":"95","author":"Qian","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.05.009_bib20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ophtha.2011.11.030","article-title":"Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results","volume":"119","author":"Rudnisky","year":"2012","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2014.05.009_bib21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/ICO.0b013e318245c02a","article-title":"Infectious keratitis after Boston type 1 keratoprosthesis implantation","volume":"31","author":"Chan","year":"2012","journal-title":"Cornea"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:12:03Z","timestamp":1757596323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939414002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0002939414002438"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2014.05.009","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Following Boston Type 1 Keratoprosthesis Implantation in Aniridia Patients at the University of Montreal","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}